Kirchhoff's Laws and Hepatic Clearance, Well-Stirred Model - Is There Common Ground?

Malcolm Rowland1, Michael Weiss2, K Sandy Pang2

  • 1Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, United Kingdom (M.R.); Department of Pharmacology, Martin Luther University Halle-Wittenberg, Halle, Germany (M.W.); and Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada (K.S.P.) mrow190539@aol.com.

Summary

This commentary refutes claims that Kirchhoff's electrical laws can model hepatic clearance, showing they rely on the same assumptions as the well-stirred model (WSM). Applying Kirchhoff's laws to organ clearance is inappropriate and potentially dangerous.

Related Concept Videos

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
144
Kirchhoff's Current Law01:04

Kirchhoff's Current Law

In the realm of electrical engineering, physicist Gustav Robert Kirchhoff made a significant contribution in 1847 by introducing Kirchhoff's laws for electric circuit analysis. These laws, particularly Kirchhoff's Current Law (KCL), have become foundational principles in understanding and analyzing electrical circuits.
Kirchhoff's Current Law is based on the principle of charge conservation. It states that at any node (a point where two or more circuit elements meet) in an...
1.1K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
61
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
79
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
102
Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
2.3K